Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

BACKGROUND: Increases in measured inulin clearance, measured creatinine clearance, and estimated glomerular filtration rate (eGFR) have been observed with bardoxolone methyl in 7 studies enrolling approximately 2,600 patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). The largest o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Nephrol
Главные авторы: Chin, Melanie P., Bakris, George L., Block, Geoffrey A., Chertow, Glenn M., Goldsberry, Angie, Inker, Lesley A., Heerspink, Hiddo J.L., O'Grady, Megan, Pergola, Pablo E., Wanner, Christoph, Warnock, David G., Meyer, Colin J.
Формат: Artigo
Язык:Inglês
Опубликовано: S. Karger AG 2018
Предметы:
Original Report: Patient-Oriented, Translational Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841134/
https://ncbi.nlm.nih.gov/pubmed/29402767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486398
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы